Stockreport

VolitionRX Ltd's (VNRX) CEO Cameron Reynolds on Q2 2018 Results - Earnings Call Transcript [Seeking Alpha]

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com
PDF VolitionRX Limited (NYSEMKT: VNRX ) Q2 2018 Earnings Conference Call August 14, 2018 8:30 AM ET Executives Scott Powell – Executive Vice President-Investor Re [Read more]